Selected diagnostic problems in neoplastic dermatopathology

Archives of Pathology and Laboratory Medicine

Volumn 131, Issue 3, 2007, Pages 434-439

  DiCaudo, David J ^a   McCalmont, Timothy H ^b   Wick, Mark R ^c  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF VIRGINIA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLUE NEVUS; BREAST CARCINOMA; CELL PROLIFERATION; CELL STRUCTURE; DERMATOFIBROMA; DESMOPLASTIC MALIGNANT MELANOMA; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; EPITHELIOID SARCOMA; FIBROMA; HISTOPATHOLOGY; HUMAN; LEIOMYOMA; MELANOMA; METASTASIS; NEUROFIBROMA; NEVOID MALIGNANT MELANOMA; PSEUDOPANNICULITIC CUTANEOUS LYMPHOMA; PUBLICATION; REVIEW; SCAR; SKIN CANCER; SPINDLE CELL; SUBCUTANEOUS LYMPHOMA;

BREAST NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; HUMANS; LYMPHOMA; MELANOMA; SARCOMA; SKIN NEOPLASMS;

EID: 33847684863     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Review

References (72)

1. McCarthy SW, Scolyer RA, Palmer AA. Desmoplastic melanoma: a diagnostic trap for the unwary. Pathology. 2004;36:445-451.
2. Troxel DB. Pitfalls in the diagnosis of malignant melanoma: findings of a risk management panel study. Am J Surg Pathol. 2003;27:1278-1283.
3. Wharton JM, Carlson JA, Mihm MC Jr. Desmoplastic malignant melanoma: diagnosis of early clinical lesions. Hum Pathol. 1999;30:537-542.
4. Skelton HG, Smith KJ, Laskin WB, et al. Desmoplastic malignant melanoma. J Am Acad Dermatol. 1995;32:717-725.
5. Egbert B, Kempson R, Sagebiel R. Desmoplastic malignant melanoma: a clinicohistopathologic study of 25 cases. Cancer. 1988;62:2033-2041.
6. Ackermann DM, Polk HC Jr, Schrodt CR. Desmoplastic melanoma of the anus. Hum Pathol. 1985;16:1277-1279.
7. Kilpatrick SE, White WL, Browne JD. Desmoplastic malignant melanoma of the oral mucosa: an underrecognized diagnostic pitfall. Cancer. 1996;78:383-389.
8. Mulvany NJ, Sykes P. Desmoplastic melanoma of the vulva. Pathology. 1997;29:241-245.
9. Busam KJ. Cutaneous desmoplastic melanoma. Adv Anat Pathol. 2005;12:92-102.
10. Magro CM, Crowson AN, Mihm MC. Unusual variants of malignant melanoma. Mod Pathol. 2006;19(suppl 2):S41-S70.
11. Posther KE, Selim MA, Mosca PJ, et al. Histopathologic characteristics, recurrence patterns, and survival of 129 patients with desmoplastic melanoma. Ann Surg Oncol. 2006;13:728-739.
12. Busam KJ, Mujumdar U, Hummer AJ, et al. Cutaneous desmoplastic melanoma: reappraisal of morphologic heterogeneity and prognostic factors. Am J Surg Pathol. 2004;28:1518-1525.
13. Harris CR, Shea CR, Horenstein MG, et al. Desmoplastic (sclerotic) nevus: an underrecognized entity that resembles dermatofibroma and desmoplastic melanoma. Am J Surg Pathol. 1999;23:786-794.
14. Winnepenninckx V, De Vos R, Stas M, van den Oord JJ. New phenotypical and ultrastructural findings in spindle cell (desmoplastic/neurotropic)melanoma. Appl Immunohistochem Mol Morphol. 2003;11:319-325.
15. Carlson JA, Dickersin CR, Sober AJ, Barnhill RL. Desmoplastic neurotropic melanoma: a clinicopathologic analysis of 28 cases. Cancer. 1995;75:478-494.
16. Anstey A, Cerio R, Ramnarain N, et al. Desmoplastic malignant melanoma: an immunocytochemical study of 25 cases. Am J Dermatopathol. 1994;16:14-22.
17. Busam KJ, Chen YT, Old LJ, et al. Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma. Am J Surg Pathol. 1998;22:976-982.
18. Busam KJ, Kucukgol D, Sato E, et al. Immunohistochemical analysis of novel monoclonal antibody PNL2 and comparison with other melanocyte differentiation markers. Am J Surg Pathol. 2005;29:400-406.
19. Kucher C, Zhang PJ, Pasha T, et al. Expression of Melan-A and Ki-67 in desmoplastic melanoma and desmoplastic nevi. Am J Dermatopathol. 2004;26:452-457.
20. Eng W, Tschen JA. Comparison of S-100 versus hematoxylin and eosin staining for evaluating dermal invasion and peripheral margins by desmoplastic malignant melanoma. Am J Dermatopathol. 2000;22:26-29.
21. Chorny JA, Barr RJ. S100-positive spindle cells in scars: a diagnostic pitfall in the re-excision of desmoplastic melanoma. Am J Dermatopathol. 2002;24:309-312.
22. Kaneishi NK, Cockerell CJ. Histologic differentiation of desmoplastic melanoma from cicatrices. Am J Dermatopathol. 1998;20:128-134.
23. Robson A, Allen P, Hollowood K. S100 expression in cutaneous scars: a potential diagnostic pitfall in the diagnosis of desmoplastic melanoma. Histopathology. 2001;38:135-140.
24. Hoang MP, Selim MA, Bentley RC, Burchette JL, Shea CR. CD34 expression in desmoplastic melanoma. J Cutan Pathol. 2001;28:508-512.
25. Riccioni L, Di Tommaso L, Collina C, Actin-rich desmoplastic malignant melanoma: report of three cases. Am J Dermatopathol. 1999;21:537-541.
26. Jensen K, Wilkinson B, Wines N, Kossard S. Procollagen 1 expression in atypical fibroxanthoma and other tumors. J Cutan Pathol. 2004;31:57-61.
27. Busam KJ, Iversen K, Coplan KC, Jungbluth AA. Analysis of microphthalmia transcription factor expression in normal tissues and tumors, and comparison of its expression with S-100 protein, gp100, and tyrosinase in desmoplastic malignant melanoma. Am J Surg Pathol. 2001;25:197-204.
28. Koch MB, Shih IM, Weiss SW, Folpe AL. Microphthalmia transcription factor and melanoma cell adhesion molecule expression distinguish desmoplastic/spindle cell melanoma from morphologic mimics. Am J Surg Pathol. 2001;25:58-64.
29. Granter SR, Weilbaecher KN, Quigley C, Fletcher CD, Fisher DE. Microphthalmia transcription factor: not a sensitive or specific marker for the diagnosis of desmoplastic melanoma and spindle cell (non-desmoplastic) melanoma. Am J Dermatopathol. 2001;23:185-189.
30. Iwamoto S, Odland PB, Piepkorn M, Bothwell M. Evidence that the p75 neurotrophin receptor mediates perineural spread of desmoplastic melanoma. J Am Acad Dermatol. 1996;35:725-731.
31. Iwamoto S, Burrows RC, Agoff SN, et al. The p75 neurotrophin receptor, relative to other Schwann cell and melanoma markers, is abundantly expressed in spindled melanomas. Am J Dermatopathol. 2001;23:288-294.
32. Kanik AB, Yaar M, Bhawan J. p75 nerve growth factor receptor staining helps identify desmoplastic and neurotropic melanoma. J Curan Pathol. 1996;23:205-210.
33. Radfar A, Stefanato CM, Ghosn S, Bhawan J. NGFR-positive desmoplastic melanomas with focal or absent S-100 staining: further evidence supporting the use of both NGFR and S-100 as a primary immunohistochemical panel for the diagnosis of desmoplastic melanomas. Am J Dermatopathol. 2006;28:162-167.
34. Blessing K, Grant JJ, Sanders DS, et al. Small cell malignant melanoma: a variant of naevoid melanoma: clinicopathological features and histological differential diagnosis. J Clin Pathol. 2000;53:591-595.
35. Blessing K, Evans AT, al-Nafussi A. Verrucous naevoid and keratotic malignant melanoma: a clinico-pathological study of 20 cases. Histopathology. 1993;23:453-458.
36. Zembowicz A, McCusker M, Chiarelli C, et al. Morphological analysis of nevoid melanoma: a study of 20 cases with a review of the literature. Am J Dermatopathol. 2001;23:167-175.
37. Schmoeckel C, Castro CE, Braun-Falco O. Nevoid malignant melanoma. Arch Dermatol Res. 1985;277:362-369.
38. McNutt NS, Urmacher C, Hakimian J, Hoss DM, Lugo J. Nevoid malignant melanoma: morphologic patterns and immunohistochemical reactivity. J Cutan Pathol. 1995;22:502-517.
39. McNutt NS. "Triggered trap": nevoid malignant melanoma. Semin Diagn Pathol. 1998;15:203-209.
40. Wong TY, Suster S, Duncan LM, Mihm MC Jr. Nevoid melanoma: a clinicopathological study of seven cases of malignant melanoma mimicking spindle and epithelioid cell nevus and verrucous dermal nevus. Hum Pathol. 1995;26:171-179.
41. Kossard S, Wilkinson B. Small cell (naevoid) melanoma: a clinicopathologic study of 131 cases. Australas J Dermatol. 1997;38(suppl 1):S54-S58.
42. Nagasaka T, Lai R, Medeiros LJ, et al. Cyclin D1 overexpression in Spitz nevi: an immunohistochemical study. Am J Dermatopathol. 1999;21:115-120.
43. Wick MR, Patterson JW. Cutaneous melanocytic lesions: selected problem areas. Am J Clin Pathol. 2005;124(suppl):S52-S83.
44. Santucci M, Pimpinelli N, Massi D, et al. Cytotoxic/natural killer cell cutaneous lymphomas: report of EORTC Cutaneous Lymphoma Task Force Workshop. Cancer. 2003;97:610-627.
45. Massone C, Chott A, Metze D, et al. Subcutaneous, blastic natural killer (NK), NK/T-cell, and other cytotoxic lymphomas of the skin: a morphologic, immunophenotypic, and molecular study of 50 patients. Am J Surg Pathol. 2004;28:719-735.
46. Magro CM, Crowson AN, Kovatich AJ, Burns F. Lupus profundus, indeterminate lymphocytic lobular panniculitis and subcutaneous T-cell lymphoma: a spectrum of subcuticular T-cell lymphoid dyscrasia. J Cutan Pathol. 2001;28:235-247.
47. Massone C, Kodama K, Salmhofer W, et al. Lupus erythematosus panniculitis (lupus profundus): clinical, histopathological, and molecular analysis of nine cases. J Cutan Pathol. 2005;32:396-404.
48. Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105:3768-3785.
49. Toro JR, Beaty M, Sorbara L, et al. Gamma delta T-cell lymphoma of the skin: a clinical, microscopic, and molecular study. Arch Dermatol. 2000;136:1024-1032.
50. Munn SE, McGregor JM, Jones A, et al. Clinical and pathological heterogeneity in cutaneous gamma-delta T-cell lymphoma: a report of three cases and a review of the literature. Br J Dermatol. 1996;135:976-981.
51. Ma L, Bandarchi B, Glusac EJ. Fatal subcutaneous panniculitis-like T-cell lymphoma with interface change and dermal mucin, a dead ringer for lupus erythematosus. J Cutan Pathol. 2005;32:360-365.
52. Yiannias JA, Maskin E, DiCaudo DJ. Peripheral T-cell lymphoma presenting as lipoatrophy and nodules. Int J Dermatol. 2006;45:1415-1419.
53. Cho KH, Oh JK, Kim CW, Heo DS, Kim ST. Peripheral T-cell lymphoma involving subcutaneous tissue. Br J Dermatol. 1995;132:290-295.
54. Lookingbill DP, Spangler N, Helm KF. Cutaneous metastases in patients with metastatic carcinoma: a retrospective study of 4020 patients. J Am Acad Dermatol. 1993;29:228-236.
55. Brownstein MH, Helwig EB. Metastatic tumors of the skin. Cancer. 1972;29:1298-1307.
56. Requena L, Sanchez Yus E, Nunez C, White CR Jr, Sangueza OP. Epidermotropically metastatic breast carcinomas: rare histopathologic variants mimicking melanoma and Paget's disease. Am J Dermatopathol. 1996;18:385-395.
57. Schwartz RA. Histopathologic aspects of cutaneous metastatic disease. J Am Acad Dermatol. 1995;33:649-657.
58. Schwartz RA. Cutaneous metastatic disease. J Am Acad Dermatol. 1995;33:161-182; quiz 183-166.
59. Brownstein MH, Helwig EB. Spread of tumors to the skin. Arch Dermatol. 1973;107:80-86.
60. Hood CI, Font RL, Zimmerman LE. Metastatic mammary carcinoma in the eyelid with histiocytoid appearance. Cancer. 1973;31:793-800.
61. Ormsby AH, Snow JL, Su WP, Goellner JR. Diagnostic immunohistochemistry of cutaneous metastatic breast carcinoma: a statistical analysis of the utility of gross cystic disease fluid protein-15 and estrogen receptor protein. J Am Acad Dermatol. 1995;32:711-716.
62. Han JH, Kang Y, Shin HC, et al. Mammaglobin expression in lymph nodes is an important marker of metastatic breast carcinoma. Arch Pathol Lab Med. 2003;127:1330-1334.
63. Enzinger FM. Epithelioid sarcoma: a sarcoma simulating a granuloma or a carcinoma. Cancer. 1970;26:1029-1041.
64. de Visscher SA, van Ginkel RJ, Wobbes T, et al. Epithelioid sarcoma: still an only surgically-curable disease. Cancer. 2006;107:606-612.
65. Fisher C. Epithelioid sarcoma of Enzinger. Adv Anat Pathol. 2006;13:114-121.
66. Lopez-Rios F, Rodriguez-Peralto JL, Castano E, Gil R. Epithelioid sarcoma masquerading as perforating granuloma annulare. Histopathology. 1997;31:102-103.
67. Heenan PJ, Quirk CJ, Papadimitriou JM. Epithelioid sarcoma: a diagnostic problem. Am J Dermatopathol. 1986;8:95-104.
68. Wick MR, Manivel JC. Epithelioid sarcoma and isolated necrobiotic granuloma: a comparative immunocytochemical study. J Cutan Pathol. 1986;13:253-260.
69. Trotter MJ, Crawford RI, O'Connell JX, Tron VA. Mitotic granuloma annulare: a clinicopathologic study of 20 cases. J Cutan Pathol. 1996;23:537-545.
70. Patterson JW. Rheumatoid nodule and subcutaneous granuloma annulare: a comparative histologic study. Am J Dermatopathol. 1988;10:1-8.
71. Chase DR, Enzinger FM, Weiss SW, Langloss JM. Keratin in epithelioid sarcoma: an immunohistochemical study. Am J Surg Pathol. 1984;8:435-441.
72. Arber DA, Kandalaft PL, Mehta P, Battifora H. Vimentin-negative epithelioid sarcoma. The value of an immunohistochemical panel that includes CD34. Am J Surg Pathol. 1993;17:302-307.